Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![BridgeBio Pharma, Inc. Common Stock Graphic](https://lunarcrush.com/gi/w:26/t:$bbio.png) BridgeBio Pharma, Inc. Common Stock (BBIO)

BridgeBio Pharma (BBIO) hits a 1-year high driven by positive clinical data and potential M&A interest. Influential creators are mentioning the stock with high engagement.

### About BridgeBio Pharma, Inc. Common Stock
BridgeBio Pharma, Inc. Common Stock (BBIO) is a biotechnology company focused on developing and delivering medicines for genetic diseases and cancers.  
BridgeBio Pharma, Inc. Common Stock uses the ticker $BBIO for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$bbio/insights)
- BridgeBio Pharma, Inc. Common Stock Price hit a high of XXXXX for the hour
- BridgeBio Pharma, Inc. Common Stock Price hit an all time of XXXXX for the hour

### Price: $XXXXX [#](/topic/$bbio/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/$bbio/time-series/close.tsv)  
The stock price is at a 1-year high, up XXXX% in the last XX hours, fueled by positive sentiment from clinical data, growth potential, and potential M&A activity, as many social posts suggest. The surge in social dominance, engagements, and market cap further supports the positive price action.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| -XXXX%  | XXXX% | XXXXX% |

**1-Year High**: $XXXXX on 2025-07-14  
**1-Year Low**: $XXXXX on 2024-11-18  
  
  
### AltRank: XXXXX [#](/topic/$bbio/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/$bbio/time-series/alt_rank.tsv)  
BridgeBio Pharma, Inc. Common Stock (BBIO) is currently AltRank #1,018 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXXXX +472  
**1 Month**: XXXXX -XX  
**6 Months**: XXXXX +720  
**1 Year**: XXXXX +285  
**1-Year High**: XXXXX on 2025-05-28  
**1-Year Low**: X on 2024-11-24  
  
  
### Galaxy Score: XXXXX [#](/topic/$bbio/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/$bbio/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX -XX  
**1 Month**: XX -XX  
**6 Months**: XX -XX  
**1 Year**: XX +14  
**1-Year High**: XX on 2025-02-04  
**1-Year Low**: X on 2024-10-15  
  
  
### Engagements: XXXXXX [#](/topic/$bbio/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$bbio/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXXX -XX%  
**1 Month**: XXXXXXX +41%  
**6 Months**: XXXXXXXXX -XX%  
**1 Year**: XXXXXXXXXX +98%  
**1-Year High**: XXXXXXX on 2024-11-25  
**1-Year Low**: XXX on 2024-12-27  

| Social Network | X      | Reddit |
| -------------- | -      | ------ |
| Engagements    | XXXXXX | X      |
  

  
  
### Mentions: XXX [#](/topic/$bbio/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$bbio/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX +264%  
**6 Months**: XXXXX -XX%  
**1 Year**: XXXXX +207%  
**1-Year High**: XXX on 2024-11-25  
**1-Year Low**: XX on 2024-07-31  

| Social Network | X   | Reddit |
| -------------- | -   | ------ |
| Mentions       | XXX | X      |
  

  
  
### Creators: XX [#](/topic/$bbio/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$bbio/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning BridgeBio Pharma, Inc. Common Stock (BBIO) in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX +513%  
**6 Months**: XXXXX +27%  
**1 Year**: XXXXX +257%  
**1-Year High**: XXX on 2024-11-26  
**1-Year Low**: XX on 2024-07-31  

The most influential creators that mention BridgeBio Pharma, Inc. Common Stock in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | X    | XXXXX     | X     | XXX         |
| [@linhnguyen64143](/creator/twitter/linhnguyen64143) | X    | XX        | X     | XXX         |

[View More](/list/creators/$bbio/100)
  
  
### Sentiment: XX% [#](/topic/$bbio/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$bbio/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% +3%  
**1 Month**: XX% -XX%  
**6 Months**: XX% -X%  
**1 Year**: XX% +10%  
**1-Year High**: XXX% on 2024-07-31  
**1-Year Low**: XX% on 2024-11-01  

**Most Supportive Themes**
- **Positive Clinical Data:** (36%) Positive clinical data, particularly regarding Acoramidis, are driving optimism among investors.
- **Commercial Viability and Growth Potential:** (31%) Analysts and investors express confidence in BridgeBio's commercial viability and potential for growth.
- **Acquisition Potential and Industry Comparisons:** (21%) Comparisons to other successful biotech companies and mentions of potential M&A activity suggest a positive outlook.
  
**Most Critical Themes**
- **Competition and Market Challenges:** (7%)  Concerns about competition from established players in the market.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXX    | XX% | XXXXXX  | XX% | XXXXX    | XX% |
| Reddit  | X        | X%  | X       | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXXXX    | XX% | XXXXXX  | XX% | XXXXX    | XX% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/$bbio/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:social_dominance.svg)  
[Social Dominance 24-Hour Chart Data](/topic/$bbio/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXX%  
**1 Week**: XXXXX% -XXXXXXX%  
**1 Month**: XXXXX% -XXXXX%  
**6 Months**: XXXXX% -XXXX%  
**1 Year**: XXXXX% +0.002%  
**1-Year High**: XXXX% on 2024-11-25  
**1-Year Low**: XXXXXX% on 2024-07-31  
  
  
### Market Dominance: XXXXX% [#](/topic/$bbio/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:market_dominance.svg)  
[Market Dominance 24-Hour Chart Data](/topic/$bbio/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2024-09-07  
**1-Year Low**: XXXXXXX% on 2025-03-11  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$bbio/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$bbio/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/$bbio/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX +$0.04%  
**1 Month**: $XXXXXXXXXXXXX +$16%  
**6 Months**: $XXXXXXXXXXXXX +$38%  
**1 Year**: $XXXXXXXXXXXXX +$82%  
**1-Year High**: $XXXXXXXXXXXXX on 2025-07-14  
**1-Year Low**: $XXXXXXXXXXXXX on 2024-11-18  

**Top assets mentioned**
In the posts about BridgeBio Pharma, Inc. Common Stock in the last XX hours

[Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny)
[Bitcoin Incognito (XBI)](/topic/$xbi)
[Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/alnylam-pharmaceuticals-inc)
[Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[TG Therapeutics, Inc. (TGTX)](/topic/$tgtx)
[Insmed, Inc. (INSM)](/topic/$insm)
[Eli Lilly and Company (LLY)](/topic/$lly)
[Akropolis (AKRO)](/topic/$akro)

**Top topics mentioned**
In the posts about BridgeBio Pharma, Inc. Common Stock in the last XX hours

[$alny](/topic/$alny), [$xbi](/topic/$xbi), [stocks](/topic/stocks), [stocks healthcare](/topic/stocks-healthcare), [nvda](/topic/nvda), [$vrna](/topic/$vrna), [amzn](/topic/amzn), [alnylam pharmaceuticals inc](/topic/alnylam-pharmaceuticals-inc), [pfe](/topic/pfe), [$mdgl](/topic/$mdgl), [hood](/topic/hood), [spx](/topic/spx), [$1211hk](/topic/$1211hk), [byd](/topic/byd), [$jcap](/topic/$jcap), [$ppta](/topic/$ppta), [$ptn](/topic/$ptn), [ibkr](/topic/ibkr), [msft](/topic/msft), [asts](/topic/asts), [$pfe](/topic/$pfe), [pltr](/topic/pltr), [balance sheet](/topic/balance-sheet), [acquisition](/topic/acquisition), [alt](/topic/alt), [$tgtx](/topic/$tgtx), [$insm](/topic/$insm), [coins healthcare](/topic/coins-healthcare), [$lly](/topic/$lly), [aes](/topic/aes), [$akro](/topic/$akro), [qqq](/topic/qqq), [$nvs](/topic/$nvs), [op](/topic/op), [$srpt](/topic/$srpt), [$nktr](/topic/$nktr), [$vktx](/topic/$vktx), [$mirm](/topic/$mirm), [investment](/topic/investment), [nxt](/topic/nxt), [oust](/topic/oust), [$bk](/topic/$bk), [$mgx](/topic/$mgx), [$prme](/topic/$prme), [$veon](/topic/$veon), [sap](/topic/sap), [$zyme](/topic/$zyme), [sonn](/topic/sonn), [ndaq](/topic/ndaq), [$twnp](/topic/$twnp), [Sentiment](/topic/sentiment), [market cap](/topic/market-cap), [$atat](/topic/$atat), [$txn](/topic/$txn), [$edit](/topic/$edit), [$cdtx](/topic/$cdtx), [$dell](/topic/$dell), [$qntm](/topic/$qntm), [$lyel](/topic/$lyel), [$byd](/topic/$byd), [srm](/topic/srm), [meta](/topic/meta), [coins energy](/topic/coins-energy), [manat](/topic/manat), [stockmarket](/topic/stockmarket), [$gpcr](/topic/$gpcr), [$rapt](/topic/$rapt), [united states](/topic/united-states), [cfg](/topic/cfg), [$tnxp](/topic/$tnxp), [$imcr](/topic/$imcr), [$nbix](/topic/$nbix), [realworld](/topic/realworld), [$20b](/topic/$20b), [$4b](/topic/$4b), [eli lilly](/topic/eli-lilly), [$rzlt](/topic/$rzlt), [$rare](/topic/$rare), [$prm](/topic/$prm), [$qure](/topic/$qure), [$psnl](/topic/$psnl), [kol](/topic/kol), [hwm](/topic/hwm), [mstr](/topic/mstr), [$300m](/topic/$300m), [$asnd](/topic/$asnd), [$bayzf](/topic/$bayzf), [stx](/topic/stx), [jbl](/topic/jbl), [$knsa](/topic/$knsa), [drugs](/topic/drugs), [$tlx](/topic/$tlx), [nem](/topic/nem), [ego](/topic/ego), [$shak](/topic/$shak), [mira](/topic/mira), [$oust](/topic/$oust), [$vst](/topic/$vst), [$nrg](/topic/$nrg), [$ipsc](/topic/$ipsc)

### Top Social Posts [#](/topic/$bbio/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"💐 🌻 🌻 I made $17300 this week with the help of @m3m3k45. Their strategy is simple to understand and works great. Awesome $NVDA $TSLA $AMZN $PLTR $AAPL $MIRA $AIRE $NCL $AEBI $XPOF $MINM $MDBH $ZBAO $SCWO $TELO $BZAI $TLN $VLCN $HOWL $BBIO $PRZO $KELYA $SNSE"  
[@slee_petrl_](/creator/x/slee_petrl_) on [X](/post/tweet/1946289066007515353) 2025-07-18 19:20:48 UTC X followers, XX engagements


"$srrk Truist upgrade. IMHO $bbio has limited upside (even with outright buyout)"  
[@BigChodu](/creator/x/BigChodu) on [X](/post/tweet/1946204363896021290) 2025-07-18 13:44:13 UTC 1552 followers, XXX engagements


"$NVS Novartis CFO on M&A + Not prioritizing Share Buybacks over Bolt-On M&A + Looking at bigger Bolt-On Deals + Have excellent BD and M&A Team + Have $XX Billion Free Cash Flow $XBI $MDGL $BBIO $TGTX $CYTK"  
[@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946170474947375193) 2025-07-18 11:29:33 UTC 7054 followers, 5098 engagements


"His accuracy is 80%-90% he deserves attention.💼 @kc1seungyeon $INTG $NXGL $LTC $ASM $GNLN $QSEAU $MLSS $COPL $NNI $NMS $LEG $TOPS $RKLB $MSAI $MSM $JBSS $ASB $MTAL $TEAD $PSHG $JBI $AOSL $FFWM $ORMP $IZEA $FAT $BBIO $RAPP"  
[@Amy071744659939](/creator/x/Amy071744659939) on [X](/post/tweet/1946071579378770084) 2025-07-18 04:56:35 UTC X followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BridgeBio Pharma, Inc. Common Stock Graphic BridgeBio Pharma, Inc. Common Stock (BBIO)

BridgeBio Pharma (BBIO) hits a 1-year high driven by positive clinical data and potential M&A interest. Influential creators are mentioning the stock with high engagement.

About BridgeBio Pharma, Inc. Common Stock

BridgeBio Pharma, Inc. Common Stock (BBIO) is a biotechnology company focused on developing and delivering medicines for genetic diseases and cancers.
BridgeBio Pharma, Inc. Common Stock uses the ticker $BBIO for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

  • BridgeBio Pharma, Inc. Common Stock Price hit a high of XXXXX for the hour
  • BridgeBio Pharma, Inc. Common Stock Price hit an all time of XXXXX for the hour

Price: $XXXXX #


Price Line Chart
Price 24-Hour Chart Data
The stock price is at a 1-year high, up XXXX% in the last XX hours, fueled by positive sentiment from clinical data, growth potential, and potential M&A activity, as many social posts suggest. The surge in social dominance, engagements, and market cap further supports the positive price action.

24-Hour 7-Day 30-Day
-XXXX% XXXX% XXXXX%

1-Year High: $XXXXX on 2025-07-14
1-Year Low: $XXXXX on 2024-11-18

AltRank: XXXXX #


AltRank Line Chart
AltRank 24-Hour Chart Data
BridgeBio Pharma, Inc. Common Stock (BBIO) is currently AltRank #1,018 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXXXX +472
1 Month: XXXXX -XX
6 Months: XXXXX +720
1 Year: XXXXX +285
1-Year High: XXXXX on 2025-05-28
1-Year Low: X on 2024-11-24

Galaxy Score: XXXXX #


Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX +14
1-Year High: XX on 2025-02-04
1-Year Low: X on 2024-10-15

Engagements: XXXXXX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXXX -XX%
1 Month: XXXXXXX +41%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXXX +98%
1-Year High: XXXXXXX on 2024-11-25
1-Year Low: XXX on 2024-12-27

Social Network X Reddit
Engagements XXXXXX X

Mentions: XXX #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX +264%
6 Months: XXXXX -XX%
1 Year: XXXXX +207%
1-Year High: XXX on 2024-11-25
1-Year Low: XX on 2024-07-31

Social Network X Reddit
Mentions XXX X

Creators: XX #


Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning BridgeBio Pharma, Inc. Common Stock (BBIO) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
1 Week: XXX -XX%
1 Month: XXXXX +513%
6 Months: XXXXX +27%
1 Year: XXXXX +257%
1-Year High: XXX on 2024-11-26
1-Year Low: XX on 2024-07-31

The most influential creators that mention BridgeBio Pharma, Inc. Common Stock in the last XX hours

Creator Rank Followers Posts Engagements
@Andre_AGTC X XXXXX X XXX
@linhnguyen64143 X XX X XXX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +3%
1 Month: XX% -XX%
6 Months: XX% -X%
1 Year: XX% +10%
1-Year High: XXX% on 2024-07-31
1-Year Low: XX% on 2024-11-01

Most Supportive Themes

  • Positive Clinical Data: (36%) Positive clinical data, particularly regarding Acoramidis, are driving optimism among investors.
  • Commercial Viability and Growth Potential: (31%) Analysts and investors express confidence in BridgeBio's commercial viability and potential for growth.
  • Acquisition Potential and Industry Comparisons: (21%) Comparisons to other successful biotech companies and mentions of potential M&A activity suggest a positive outlook.

Most Critical Themes

  • Competition and Market Challenges: (7%) Concerns about competition from established players in the market.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXXX XX% XXXXX XX%
Reddit X X% X X% X X%
Total XXXXX XX% XXXXXX XX% XXXXX XX%

Social Dominance: XXXXX% #


Social Dominance Line Chart
Social Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: XXXX%
1 Week: XXXXX% -XXXXXXX%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% -XXXX%
1 Year: XXXXX% +0.002%
1-Year High: XXXX% on 2024-11-25
1-Year Low: XXXXXX% on 2024-07-31

Market Dominance: XXXXX% #


Market Dominance Line Chart
Market Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-09-07
1-Year Low: XXXXXXX% on 2025-03-11

Market Cap: $XXXXXXXXXXXXX #


Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$0.04%
1 Month: $XXXXXXXXXXXXX +$16%
6 Months: $XXXXXXXXXXXXX +$38%
1 Year: $XXXXXXXXXXXXX +$82%
1-Year High: $XXXXXXXXXXXXX on 2025-07-14
1-Year Low: $XXXXXXXXXXXXX on 2024-11-18

Top assets mentioned In the posts about BridgeBio Pharma, Inc. Common Stock in the last XX hours

Alnylam Pharmaceuticals, Inc. (ALNY) Bitcoin Incognito (XBI) Alnylam Pharmaceuticals, Inc. (ALNY) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Pfizer, Inc. (PFE) TG Therapeutics, Inc. (TGTX) Insmed, Inc. (INSM) Eli Lilly and Company (LLY) Akropolis (AKRO)

Top topics mentioned In the posts about BridgeBio Pharma, Inc. Common Stock in the last XX hours

$alny, $xbi, stocks, stocks healthcare, nvda, $vrna, amzn, alnylam pharmaceuticals inc, pfe, $mdgl, hood, spx, $1211hk, byd, $jcap, $ppta, $ptn, ibkr, msft, asts, $pfe, pltr, balance sheet, acquisition, alt, $tgtx, $insm, coins healthcare, $lly, aes, $akro, qqq, $nvs, op, $srpt, $nktr, $vktx, $mirm, investment, nxt, oust, $bk, $mgx, $prme, $veon, sap, $zyme, sonn, ndaq, $twnp, Sentiment, market cap, $atat, $txn, $edit, $cdtx, $dell, $qntm, $lyel, $byd, srm, meta, coins energy, manat, stockmarket, $gpcr, $rapt, united states, cfg, $tnxp, $imcr, $nbix, realworld, $20b, $4b, eli lilly, $rzlt, $rare, $prm, $qure, $psnl, kol, hwm, mstr, $300m, $asnd, $bayzf, stx, jbl, $knsa, drugs, $tlx, nem, ego, $shak, mira, $oust, $vst, $nrg, $ipsc

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"💐 🌻 🌻 I made $17300 this week with the help of @m3m3k45. Their strategy is simple to understand and works great. Awesome $NVDA $TSLA $AMZN $PLTR $AAPL $MIRA $AIRE $NCL $AEBI $XPOF $MINM $MDBH $ZBAO $SCWO $TELO $BZAI $TLN $VLCN $HOWL $BBIO $PRZO $KELYA $SNSE"
@slee_petrl_ on X 2025-07-18 19:20:48 UTC X followers, XX engagements

"$srrk Truist upgrade. IMHO $bbio has limited upside (even with outright buyout)"
@BigChodu on X 2025-07-18 13:44:13 UTC 1552 followers, XXX engagements

"$NVS Novartis CFO on M&A + Not prioritizing Share Buybacks over Bolt-On M&A + Looking at bigger Bolt-On Deals + Have excellent BD and M&A Team + Have $XX Billion Free Cash Flow $XBI $MDGL $BBIO $TGTX $CYTK"
@WallStSai on X 2025-07-18 11:29:33 UTC 7054 followers, 5098 engagements

"His accuracy is 80%-90% he deserves attention.💼 @kc1seungyeon $INTG $NXGL $LTC $ASM $GNLN $QSEAU $MLSS $COPL $NNI $NMS $LEG $TOPS $RKLB $MSAI $MSM $JBSS $ASB $MTAL $TEAD $PSHG $JBI $AOSL $FFWM $ORMP $IZEA $FAT $BBIO $RAPP"
@Amy071744659939 on X 2025-07-18 04:56:35 UTC X followers, XX engagements

BridgeBio Pharma, Inc. Common Stock (BBIO)
/topic/$bbio